Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06374758 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Accelerated ART Initiation for PWHIV Who Are Out of Care

Study acronym: ACCELERATE
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 5, 2026 (before its estimated August 9, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 3 months later May 1, 2026 → Aug 9, 2026
See other at-risk trials from University of Missouri-Columbia

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing
    • Primary completion pushed from May 1, 2026 to Aug 9, 2026
    • Study completion pushed from Nov 1, 2026 to Aug 9, 2027
    • Site details revised at 4 of 4 sites
    v6
  2. Primary completion date: May 1, 2025 to May 1, 2026
    • Study sites: 3 to 4
    • Study completion date: Nov 1, 2025 to Nov 1, 2026
    v5
  3. Study sites: 1 to 3v4
  4. Primary endpoints revised (6)v3
  5. Start date changed from estimate of May 1, 2024 to Apr 29, 2024v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a standardized method for outreach, the use of telehealth for rapid access to an HIV care provider, a simplified pre-approved HIV regimen, a free 30-day medication starter supply, and re-linkage to medical care.
Trial Details
NCT Number NCT06374758
Lead Sponsor University of Missouri-Columbia
Collaborators: Gilead Sciences
Conditions
(from sponsor)		 HIV Infections, ART, Noncompliance, Patient
Related terms HIV Infections, Patient Compliance
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov